about
Genome-wide association studies identify four ER negative-specific breast cancer risk lociDo MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSA genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Large-scale genotyping identifies 41 new loci associated with breast cancer risk.The landscape of cancer genes and mutational processes in breast cancerComparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesCombined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.Landscape of somatic mutations in 560 breast cancer whole-genome sequences.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityConfirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumMicroRNA related polymorphisms and breast cancer risk.Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Five polymorphisms and breast cancer risk: results from the Breast Cancer Association ConsortiumAssociations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer riskInherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumRefined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association ConsortiumEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.Common germline polymorphisms associated with breast cancer-specific survival.19p13.1 is a triple-negative-specific breast cancer susceptibility locus.Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerIdentification of novel genetic markers of breast cancer survival.11q13 is a susceptibility locus for hormone receptor positive breast cancer.Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
P50
Q24622610-CB052E61-6059-4A7A-96A5-31792FF6F35CQ27851413-991B57E4-225D-4043-B4AD-0E597863434EQ28584533-3B0C1B4A-3204-416D-AF0F-6A38C905CDE3Q28943455-6619FB2B-2DDC-404F-A28D-0324561ED38FQ29416989-2314A9A6-AE3E-4C9E-8700-59D9001D4BF6Q29614637-F0D0476B-743B-469A-9D6B-C249AC69413EQ31082788-A752B7F4-7EE2-46AF-BCB4-EA4E50DA5BB9Q33593016-4E48C9E8-8A42-4CD1-ACA9-617DF26748F5Q33627208-70860EC1-230C-4ACA-B1B9-3F1EBCD8D7DEQ34046731-4982797A-1C83-448A-BE71-5D333A0DD0F0Q34123806-71CB3F6F-830A-4292-831B-AB9CEAD53E6BQ34145071-27C9ED93-65BF-43CE-A9B5-96929B7B68BDQ34181322-5480D3D3-9F48-4EE5-A90B-0C64F7C95441Q34327945-F8240992-35BB-48C8-A93E-1651233668D4Q34378972-8107C06A-07A8-4144-8478-B022104F5165Q34379032-4EC0113F-6549-4250-B439-31AD216D879AQ34497352-4AB8D286-8610-45F4-908D-9C90A78793BAQ34714085-2AF3E339-59A9-47B6-818B-1138022EA1E7Q34898735-B3958532-1178-480D-93B3-2B1182EC2876Q34903062-206F87DC-04D5-4646-848E-C3077AF409F0Q34979715-CECB0279-B2B7-431A-93F7-4733E89A7AF3Q35022847-F729D2FB-E0F7-48FE-AC3E-DFFA219AAF58Q35064451-6B946C0B-32E0-41A4-AB21-33D2BD616611Q35102646-9BF11DB3-6059-49FC-9078-3167F97FE7CAQ35104068-3A522F4B-8601-45FE-98F5-E61C09B2B77EQ35119701-70C780F5-9EA9-4F96-826C-75BA48D6EEF6Q35155449-9B96058E-D81F-4319-937F-B39F3E1698BAQ35179897-AAAB3E26-89C3-48D7-A288-C370ACAE0ACAQ35524465-A03D81FB-E6BF-4416-80F3-CCB2BA00A90CQ35532898-023DD73C-FFA5-4BB6-A526-F997A33A7519Q35653910-04110DEC-187B-4FD5-8207-4C07B0B5487BQ35681656-FD643A95-9A5C-4A0F-97D8-4E5F84F5B638Q35794366-E81EB747-2D9B-4344-BCEF-3A17B44FEE56Q35794653-0F24F911-9AA1-4E01-954B-7F2251D614E6Q35871567-B0BC5D86-4FDF-4AC0-B2CF-5E594DD5DB60Q35940158-9ABDC79D-5206-47ED-97C6-E8516217AEB5Q35996692-4FB9224A-371F-4946-8775-6BC838D68004Q36014067-92CDA164-A5D2-48AE-860E-10563CF1587BQ36016386-D2D2F4A5-DA8E-428B-9323-DD77BABF61DFQ36066735-E97823ED-EC9A-44C4-8016-7587DFC666EA
P50
description
Dutch researcher
@en
Nederlands onderzoekster
@nl
nederlandsk forsker
@nb
name
Annegien Broeks
@da
Annegien Broeks
@de
Annegien Broeks
@en
Annegien Broeks
@es
Annegien Broeks
@fr
Annegien Broeks
@nb
Annegien Broeks
@nl
Annegien Broeks
@nn
Annegien Broeks
@sv
type
label
Annegien Broeks
@da
Annegien Broeks
@de
Annegien Broeks
@en
Annegien Broeks
@es
Annegien Broeks
@fr
Annegien Broeks
@nb
Annegien Broeks
@nl
Annegien Broeks
@nn
Annegien Broeks
@sv
prefLabel
Annegien Broeks
@da
Annegien Broeks
@de
Annegien Broeks
@en
Annegien Broeks
@es
Annegien Broeks
@fr
Annegien Broeks
@nb
Annegien Broeks
@nl
Annegien Broeks
@nn
Annegien Broeks
@sv
P1006
P214
P1006
P106
P2038
Annegien_Broeks
P21
P214
P31
P569
1966-01-01T00:00:00Z
P7859
viaf-290007617